Related references
Note: Only part of the references are listed.Verteporfin inhibits the persistent fibrotic phenotype of lesional scleroderma dermal fibroblasts
Xu Shi-Wen et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2021)
Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis
Borja Marcos Ribes et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2020)
YAP is essential for TGF-beta-induced retinal fibrosis in diabetic rats via promoting the fibrogenic activity of Muller cells
Wei Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition
Jamie Francisco et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Inhibition of Yes-Associated Protein by Verteporfin Ameliorates Unilateral Ureteral Obstruction-Induced Renal Tubulointerstitial Inflammation and Fibrosis
Jixiu Jin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Verteporfin treatment controls morphology, phenotype, and global gene expression for cells of the human nucleus pulposus
Bailey V. Fearing et al.
JOR SPINE (2020)
Mechanical regulation of myofibroblast phenoconversion and collagen contraction
Boris Hinz et al.
EXPERIMENTAL CELL RESEARCH (2019)
Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells
Hai-xia Yu et al.
MOLECULAR IMMUNOLOGY (2019)
Role of the Hippo Pathway in Fibrosis and Cancer
Cho-Long Kim et al.
CELLS (2019)
The Molecular Pathogenesis of Dupuytren Disease Review of the Literature and Suggested New Approaches to Treatment
Lohrasb R. Sayadi et al.
ANNALS OF PLASTIC SURGERY (2019)
Shared and distinct mechanisms of fibrosis
Joerg H. W. Distler et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts
Alexandre Vallee et al.
CELL AND BIOSCIENCE (2019)
TGF signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders
Jonathon M. Carthy
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
TGF-β1 Signaling and Tissue Fibrosis
Kevin K. Kim et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
YAP/TAZ regulates TGF-beta/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts
Zhaoping Qin et al.
CELL COMMUNICATION AND SIGNALING (2018)
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells
Kuo Du et al.
GASTROENTEROLOGY (2018)
Three-year recurrence of Dupuytren's contracture after needle fasciotomy and collagenase injection: a two-centre randomized controlled trial
Peter Scherman et al.
JOURNAL OF HAND SURGERY-EUROPEAN VOLUME (2018)
Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis
Yuan Gui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Verteporfin as a Medical Treatment in Peyronie's Disease
Daan C. J. Mohede et al.
SEXUAL MEDICINE (2018)
YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Satoshi Noguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis
Akiko Futakuchi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
Molecular insights into prolyl and lysyl hydroxylation of fibrillar collagens in health and disease
Rutger A. F. Gjaltema et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Yap/Taz Deletion in Gli+ Cell-Derived Myofibroblasts Attenuates Fibrosis
Ming Liang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Sav1 Loss Induces Senescence and Stat3 Activation Coinciding with Tubulointerstitial Fibrosis
Janet Y. Leung et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Drugs and Targets in Fibrosis
Xiaoyi Li et al.
FRONTIERS IN PHARMACOLOGY (2017)
The good and the bad collagens of fibrosis - Their role in signaling and organ function
M. A. Karsdal et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis
Michael Ng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease
Evert-Jan P. M. ten Dam et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2016)
Systematic review of non-surgical treatments for early Dupuytren's disease
Catherine Ball et al.
BMC MUSCULOSKELETAL DISORDERS (2016)
Clinical Experience of the Long-term Use of Pirfenidone for Idiopathic Pulmonary Fibrosis
Masashi Bando et al.
INTERNAL MEDICINE (2016)
YAP/TAZ Are Mechanoregulators of TGF-β-Smad Signaling and Renal Fibrogenesis
Stephen G. Szeto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
Gareth Hughes et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease
Kerstin Becker et al.
PLOS ONE (2016)
YAP1 Is a Driver of Myofibroblast Differentiation in Normal and Diseased Fibroblasts
Bram Piersma et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Nintedanib and Pirfenidone New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
Inge Mannaerts et al.
JOURNAL OF HEPATOLOGY (2015)
Genetic and environmental influences in Dupuytren's disease: A study of 30,330 Danish twin pairs
S. Larsen et al.
JOURNAL OF HAND SURGERY-EUROPEAN VOLUME (2015)
Signaling in fibrosis: TGF-beta, wNT, and YAP/TAZ converge
Bram Piersma et al.
FRONTIERS IN MEDICINE (2015)
YAP and TAZ Regulate Skin Wound Healing
Min-Jung Lee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Identification of Histological Patterns in Clinically Affected and Unaffected Palm Regions in Dupuytren's Disease
Camilo-Andres Alfonso-Rodriguez et al.
PLOS ONE (2014)
Novel Ex Vivo Culture Method for the Study of Dupuytren's Disease: Effects of TGFβ Type 1 Receptor Modulation by Antisense Oligonucleotides
Sofia Karkampouna et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
PAI-1 in tissue fibrosis
Asish K. Ghosh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's - derived fibroblasts
Latha Satish et al.
BMC MUSCULOSKELETAL DISORDERS (2011)
Dupuytren Disease: An Evolving Understanding of an Age-old Disease
Eric M. Black et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2011)
Wnt Signaling and Dupuytren's Disease
Guido H. Dolmans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Elevated transforming growth factor beta and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts
Carola Krause et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Scientific understanding and clinical management of Dupuytren disease
Barbara Shih et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Injectable Collagenase Clostridium Histolyticum for Dupuytren's Contracture.
Lawrence C. Hurst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Collagen as a clinical target: Nonoperative treatment of Dupuytren's disease
MA Badalamente et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2002)
Share Paper
